• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机试验中的协方差分析:更高的精度和有效的置信区间,无需模型假设。

Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.

作者信息

Wang Bingkai, Ogburn Elizabeth L, Rosenblum Michael

机构信息

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

出版信息

Biometrics. 2019 Dec;75(4):1391-1400. doi: 10.1111/biom.13062. Epub 2019 Jun 3.

DOI:10.1111/biom.13062
PMID:31009064
Abstract

"Covariate adjustment" in the randomized trial context refers to an estimator of the average treatment effect that adjusts for chance imbalances between study arms in baseline variables (called "covariates"). The baseline variables could include, for example, age, sex, disease severity, and biomarkers. According to two surveys of clinical trial reports, there is confusion about the statistical properties of covariate adjustment. We focus on the analysis of covariance (ANCOVA) estimator, which involves fitting a linear model for the outcome given the treatment arm and baseline variables, and trials that use simple randomization with equal probability of assignment to treatment and control. We prove the following new (to the best of our knowledge) robustness property of ANCOVA to arbitrary model misspecification: Not only is the ANCOVA point estimate consistent (as proved by Yang and Tsiatis, 2001) but so is its standard error. This implies that confidence intervals and hypothesis tests conducted as if the linear model were correct are still asymptotically valid even when the linear model is arbitrarily misspecified, for example, when the baseline variables are nonlinearly related to the outcome or there is treatment effect heterogeneity. We also give a simple, robust formula for the variance reduction (equivalently, sample size reduction) from using ANCOVA. By reanalyzing completed randomized trials for mild cognitive impairment, schizophrenia, and depression, we demonstrate how ANCOVA can achieve variance reductions of 4 to 32%.

摘要

在随机试验背景下,“协变量调整”指的是对平均治疗效果的一种估计方法,该方法可针对研究组在基线变量(称为“协变量”)方面的随机失衡进行调整。基线变量可包括例如年龄、性别、疾病严重程度和生物标志物等。根据两项对临床试验报告的调查,对于协变量调整的统计特性存在混淆。我们聚焦于协方差分析(ANCOVA)估计量,它涉及为给定治疗组和基线变量的结果拟合一个线性模型,以及使用简单随机化且治疗组和对照组分配概率相等的试验。我们证明了以下(据我们所知)ANCOVA对于任意模型误设的新稳健特性:不仅ANCOVA点估计是一致的(如Yang和Tsiatis在2001年所证明),其标准误也是如此。这意味着即使线性模型被任意误设,例如当基线变量与结果非线性相关或存在治疗效果异质性时,如同线性模型正确时那样进行的置信区间和假设检验在渐近意义上仍然是有效的。我们还给出了一个使用ANCOVA进行方差缩减(等效于样本量缩减)的简单稳健公式。通过重新分析针对轻度认知障碍、精神分裂症和抑郁症的已完成随机试验,我们展示了ANCOVA如何能够实现4%至32%的方差缩减。

相似文献

1
Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.随机试验中的协方差分析:更高的精度和有效的置信区间,无需模型假设。
Biometrics. 2019 Dec;75(4):1391-1400. doi: 10.1111/biom.13062. Epub 2019 Jun 3.
2
Robustness of ANCOVA in randomized trials with unequal randomization.随机分组不均衡的随机试验中协方差分析的稳健性。
Biometrics. 2020 Sep;76(3):1036-1038. doi: 10.1111/biom.13184. Epub 2019 Dec 10.
3
Robustness of response-adaptive randomization.响应适应性随机化的稳健性。
Biometrics. 2024 Mar 27;80(2). doi: 10.1093/biomtc/ujae049.
4
A comparison of covariate adjustment approaches under model misspecification in individually randomized trials.个体随机试验中模型误设下协变量调整方法的比较。
Trials. 2023 Jan 6;24(1):14. doi: 10.1186/s13063-022-06967-6.
5
Analyzing pre-post randomized studies with one post-randomization score using repeated measures and ANCOVA models.采用重复测量和协方差分析模型分析一个后随机化评分的前后随机化研究。
Stat Methods Med Res. 2019 Oct-Nov;28(10-11):2952-2974. doi: 10.1177/0962280218789972. Epub 2018 Aug 7.
6
Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.在各群组间协方差和治疗后方差不同的情况下,对随机试验中的预处理测量值进行协方差分析。
Biom J. 2011 May;53(3):512-24. doi: 10.1002/bimj.201000200.
7
Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables.在随机试验中,使用广义线性模型利用基线变量来估计治疗效果的简单、有效方法。
Int J Biostat. 2010 Apr 1;6(1):Article 13. doi: 10.2202/1557-4679.1138.
8
Improving the mixed model for repeated measures to robustly increase precision in randomized trials.改进重复测量的混合模型以在随机试验中稳健地提高精度。
Int J Biostat. 2023 Nov 29;20(2):585-598. doi: 10.1515/ijb-2022-0101. eCollection 2024 Nov 1.
9
Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?受限平均生存时间:协变量调整能否提高随机临床试验的精度?
Clin Trials. 2018 Apr;15(2):178-188. doi: 10.1177/1740774518759281. Epub 2018 Mar 4.
10
Leveraging prognostic baseline variables to gain precision in randomized trials.利用预后基线变量提高随机试验的精准度。
Stat Med. 2015 Aug 15;34(18):2602-17. doi: 10.1002/sim.6507. Epub 2015 Apr 14.

引用本文的文献

1
A general form of covariate adjustment in clinical trials under covariate-adaptive randomization.协变量自适应随机化下临床试验中协变量调整的一般形式。
Biometrika. 2025 Apr 12;112(3):asaf029. doi: 10.1093/biomet/asaf029. eCollection 2025.
2
Feasibility and Acceptability of Online Culturally Adapted Cognitive Behavioural Therapy for Depression and Anxiety in Canadians of South Asian Origin: A Randomized Controlled Trial: Faisabilité et acceptabilité de la thérapie cognitivo-comportementale en ligne adaptée à la culture pour traiter la dépression et l'anxiété chez les Canadiens d'origine sud-asiatique : Essai contrôlé à répartition aléatoire.针对南亚裔加拿大人的抑郁症和焦虑症的在线文化适应性认知行为疗法的可行性和可接受性:一项随机对照试验:针对南亚裔加拿大人的抑郁症和焦虑症的在线文化适应性认知行为疗法的可行性和可接受性:随机对照试验
Can J Psychiatry. 2025 May 15:7067437251337644. doi: 10.1177/07067437251337644.
3
Double robust variance estimation with parametric working models.使用参数化工作模型的双重稳健方差估计
Biometrics. 2025 Apr 2;81(2). doi: 10.1093/biomtc/ujaf054.
4
Acceptability and Effectiveness of a Fully Web-Based Nutrition and Exercise Program for Individuals With Chronic Disease During COVID-19: Randomized Controlled Trial.COVID-19期间针对慢性病患者的全网络营养与运动计划的可接受性和有效性:随机对照试验
J Med Internet Res. 2025 Mar 24;27:e57537. doi: 10.2196/57537.
5
Low-volume combined aerobic and resistance high-intensity interval training in type 2 diabetes: a randomised controlled trial.低容量有氧与抗阻高强度间歇训练用于2型糖尿病:一项随机对照试验
BMJ Open Sport Exerc Med. 2024 Oct 7;10(4):e002046. doi: 10.1136/bmjsem-2024-002046. eCollection 2024.
6
Evaluation of a national program to distribute free face masks in Uganda: Evidence from Mbale District.评估乌干达全国范围内分发免费口罩计划:来自姆巴莱区的证据。
PLoS One. 2024 Jul 11;19(7):e0305574. doi: 10.1371/journal.pone.0305574. eCollection 2024.
7
Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects.在估计依从者和不依从者平均因果效应时,对主要可忽略性违反的敏感性分析。
Stat Med. 2024 Aug 30;43(19):3664-3688. doi: 10.1002/sim.10153. Epub 2024 Jun 18.
8
Robust analysis of stepped wedge trials using composite likelihood models.使用复合似然模型对阶梯式楔形试验进行稳健分析。
Stat Med. 2024 Jul 30;43(17):3326-3352. doi: 10.1002/sim.10120. Epub 2024 Jun 4.
9
Causal mediation analysis: From simple to more robust strategies for estimation of marginal natural (in)direct effects.因果中介分析:从简单到更稳健的边际自然(非)直接效应估计策略
Stat Surv. 2023;17:1-41. doi: 10.1214/22-SS140. Epub 2023 Jan 17.
10
Causal interpretation of the hazard ratio in randomized clinical trials.随机临床试验中风险比的因果解释。
Clin Trials. 2024 Oct;21(5):623-635. doi: 10.1177/17407745241243308. Epub 2024 Apr 28.